Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) – SunTrust Banks decreased their Q3 2017 earnings per share (EPS) estimates for shares of Verona Pharma PLC American Depositary Share in a research note issued to investors on Wednesday. SunTrust Banks analyst Y. Suneja now forecasts that the company will earn ($0.58) per share for the quarter, down from their prior forecast of ($0.39). SunTrust Banks currently has a “Buy” rating and a $26.00 price target on the stock. SunTrust Banks also issued estimates for Verona Pharma PLC American Depositary Share’s Q4 2017 earnings at ($0.49) EPS, FY2017 earnings at ($1.90) EPS and FY2018 earnings at ($2.37) EPS.

Several other equities research analysts have also recently weighed in on the stock. Zacks Investment Research cut shares of Verona Pharma PLC American Depositary Share from a “buy” rating to a “hold” rating in a research note on Tuesday. Jefferies Group LLC reiterated a “buy” rating and issued a $26.00 target price on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. Wedbush began coverage on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. They issued an “outperform” rating and a $25.00 target price for the company. Finally, Stifel Nicolaus began coverage on shares of Verona Pharma PLC American Depositary Share in a research note on Monday, May 22nd. They issued a “buy” rating and a $22.00 target price for the company. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus target price of $22.60.

COPYRIGHT VIOLATION NOTICE: This report was first reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another publication, it was illegally stolen and republished in violation of US & international copyright and trademark legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/11/verona-pharma-plc-american-depositary-share-expected-to-post-q3-2017-earnings-of-0-58-per-share-nasdaqvrna.html.

Shares of Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) opened at 12.24 on Friday. The company’s market capitalization is $136.01 million. The company has a 50-day moving average price of $14.17 and a 200 day moving average price of $13.83. Verona Pharma PLC American Depositary Share has a one year low of $11.03 and a one year high of $50.88.

Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) last announced its quarterly earnings data on Tuesday, August 8th. The company reported ($0.37) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.28) by $0.09.

An institutional investor recently bought a new position in Verona Pharma PLC American Depositary Share stock. Vivo Capital LLC purchased a new stake in Verona Pharma PLC American Depositary Share (NASDAQ:VRNA) during the second quarter, according to its most recent 13F filing with the SEC. The firm purchased 704,225 shares of the company’s stock, valued at approximately $8,208,000. Verona Pharma PLC American Depositary Share comprises 2.1% of Vivo Capital LLC’s investment portfolio, making the stock its 11th largest position. Vivo Capital LLC owned 10.97% of Verona Pharma PLC American Depositary Share at the end of the most recent reporting period. 5.09% of the stock is owned by hedge funds and other institutional investors.

Verona Pharma PLC American Depositary Share Company Profile

Verona Pharma plc, a clinical stage biopharmaceutical company, researches, discovers, and develops therapeutic drugs to treat respiratory diseases primarily in the United Kingdom and North America. The company’s lead product is RPL554, an inhaled dual inhibitor of the enzymes phosphodiesterase 3 and 4, which is in Phase IIa clinical trial that acts as a bronchodilator and an anti-inflammatory agent for the treatment of chronic obstructive pulmonary disease, cystic fibrosis, and asthma.

Earnings History and Estimates for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA)

Receive News & Ratings for Verona Pharma PLC American Depositary Share Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verona Pharma PLC American Depositary Share and related companies with MarketBeat.com's FREE daily email newsletter.